AI
LUMO

Atria Investments’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Atria Investments’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,803
Closed -$25.1K – 2070
2024
Q2 		$25.1K Buy
+10,803
New +$27.9K ﹤0.01% 1901

Other funds holding LUMO

PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Atria Investments's LUMO Position: Q3 2024 in Review

Atria Investments sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2024, closing a stake of 10,803 shares — an estimated $25.1K sold.

Atria Investments first reported a position in LUMO in Q2 2024 and held it in 1 quarter. The position peaked at $25.1K in Q2 2024. 28 funds tracked by Wall St. Rank hold LUMO as of Q3 2024.

  • Atria Investments reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Atria Investments sold 10,803 Lumos Pharma, Inc. Common Stock shares in Q3 2024, an estimated $25.1K.
  • Atria Investments first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Atria Investments's Lumos Pharma, Inc. Common Stock position peaked at $25.1K in Q2 2024.
  • 28 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2024.

Based on Atria Investments's 13F filing for Q3 2024, filed 1 Nov 2024.